227 related articles for article (PubMed ID: 7695507)
1. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro.
Beresford JN; Joyner CJ; Devlin C; Triffitt JT
Arch Oral Biol; 1994 Nov; 39(11):941-7. PubMed ID: 7695507
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
Leboy PS; Beresford JN; Devlin C; Owen ME
J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
[TBL] [Abstract][Full Text] [Related]
3. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2.
Rickard DJ; Sullivan TA; Shenker BJ; Leboy PS; Kazhdan I
Dev Biol; 1994 Jan; 161(1):218-28. PubMed ID: 8293874
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells.
Cheng SL; Zhang SF; Avioli LV
J Cell Biochem; 1996 May; 61(2):182-93. PubMed ID: 9173083
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures.
Beresford JN; Bennett JH; Devlin C; Leboy PS; Owen ME
J Cell Sci; 1992 Jun; 102 ( Pt 2)():341-51. PubMed ID: 1400636
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
7. Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro?
Zhou YS; Liu YS; Tan JG
Chin Med J (Engl); 2006 Aug; 119(15):1278-86. PubMed ID: 16919187
[TBL] [Abstract][Full Text] [Related]
8. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
Malaval L; Modrowski D; Gupta AK; Aubin JE
J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells.
Fromigué O; Marie PJ; Lomri A
Cytokine; 1997 Aug; 9(8):613-23. PubMed ID: 9245490
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of osteoblast precursor cells from human bone marrow.
Rickard DJ; Kassem M; Hefferan TE; Sarkar G; Spelsberg TC; Riggs BL
J Bone Miner Res; 1996 Mar; 11(3):312-24. PubMed ID: 8852942
[TBL] [Abstract][Full Text] [Related]
11. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
12. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells.
Diefenderfer DL; Osyczka AM; Garino JP; Leboy PS
J Bone Joint Surg Am; 2003; 85-A Suppl 3():19-28. PubMed ID: 12925605
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.
Kassem M; Mosekilde L; Eriksen EF
J Bone Miner Res; 1993 Dec; 8(12):1453-8. PubMed ID: 8304046
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.
Cheng SL; Yang JW; Rifas L; Zhang SF; Avioli LV
Endocrinology; 1994 Jan; 134(1):277-86. PubMed ID: 8275945
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
Atmani H; Audrain C; Mercier L; Chappard D; Basle MF
J Cell Biochem; 2002; 85(3):640-50. PubMed ID: 11968004
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3.
Thavarajah M; Evans DB; Kanis JA
Bone; 1993; 14(5):763-7. PubMed ID: 7505605
[TBL] [Abstract][Full Text] [Related]
17. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures.
Oreffo RO; Virdi AS; Triffitt JT
Eur J Cell Biol; 1997 Nov; 74(3):251-61. PubMed ID: 9402473
[TBL] [Abstract][Full Text] [Related]
18. Differential surface antigen expression and 1α,25-dihydroxyvitamin D3 responsiveness distinguish human dermal fibroblasts with age-dependent osteogenic differentiation potential from marrow-derived stromal cells in vitro.
Hee CK; Nicoll SB
Cytotherapy; 2011 May; 13(5):528-38. PubMed ID: 21171822
[TBL] [Abstract][Full Text] [Related]
19. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells.
Mendes SC; Tibbe JM; Veenhof M; Both S; Oner FC; van Blitterswijk CA; de Bruijn JD
J Mater Sci Mater Med; 2004 Oct; 15(10):1123-8. PubMed ID: 15516873
[TBL] [Abstract][Full Text] [Related]
20. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin.
Siggelkow H; Schulz H; Kaesler S; Benzler K; Atkinson MJ; Hüfner M
Calcif Tissue Int; 1999 May; 64(5):414-21. PubMed ID: 10203418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
